USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 14:59 PM 2012

NYSE 8090.47 7.49 Index Moved Up

NASDAQ 2928.81 12.95 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for SLXP and GEA...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Salix Pharmaceuticals Ltd. and

General Electric Capital Corpo

Volatility

Matrix

Run Correlation

Diversification

Very good diversification

Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and General Electric Capital Corpo in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.38

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	91.3%
Values	Daily Returns

Suggest

Salix Pharmaceuticals Ltd.

Profile

48.97

Intraday

One Month

^(0.25)

0.51%

SLXP

NASDAQ

Salix Pharmaceuticals Ltd.

P/E	37.86	Day Low	48.80
Open	49.47	P/B Ratio	6.06
Market Cap	2.896B	Volume	152889
Sector	Healthcare	Last Close	49.22
Short Ratio	7.80	Last Traded	2/9/2012
Year High	50.28	Percent Change	0.51%
EBITDA	142.7M	Year Low	25.64
Absolute Change	0.25	Time	Not Applicable
Book Value	8.127	EPS	1.30
PEG Ratio	0.94	Employees	390
Day High	49.8084	Industry	Drugs - Generic
Target Price	54.53	Current EPS	1.30
This Year EPS	2.55	Next Year EPS	2.79
Current PE	37.86	This Year PE	19.30
Next Year PE	17.64	Dividend	Not Applicable

General Electric Capital Corpor

Profile

26.47

Intraday

One Month

^(0.06)

0.21%

GEA

NYSE

General Electric Capital Corpo

Day Low	26.43	P/B Ratio	Not Applicable
Open	26.55	Market Cap	Not Applicable
Volume	58281	Last Close	26.53
Last Traded	2/9/2012	Year High	26.69
Percent Change	0.21%	EBITDA	Not Applicable
Year Low	24.10	Absolute Change	0.06
Day High	26.57	Target Price	Not Applicable
Dividend	1.656	Dividend Yield	6.24
Dividend Date	Mar 28